Department of Obstetrics, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai 200040, China.
BMC Med Genomics. 2014 Jul 7;7:42. doi: 10.1186/1755-8794-7-42.
Intrahepatic cholestasis of pregnancy (ICP) is a pregnancy-associated liver disease with potentially deleterious consequences for the fetus, particularly when maternal serum bile-acid concentration >40 μM. However, the etiology and pathogenesis of ICP remain elusive. To reveal the underlying molecular mechanisms for the association of maternal serum bile-acid level and fetal outcome in ICP patients, DNA microarray was applied to characterize the whole-genome expression profiles of placentas from healthy women and women diagnosed with ICP.
Thirty pregnant women recruited in this study were categorized evenly into three groups: healthy group; mild ICP, with serum bile-acid concentration ranging from 10-40 μM; and severe ICP, with bile-acid concentration >40 μM. Gene Ontology analysis in combination with construction of gene-interaction and gene co-expression networks were applied to identify the core regulatory genes associated with ICP pathogenesis, which were further validated by quantitative real-time PCR and histological staining.
The core regulatory genes were mainly involved in immune response, VEGF signaling pathway and G-protein-coupled receptor signaling, implying essential roles of immune response, vasculogenesis and angiogenesis in ICP pathogenesis. This implication was supported by the observed aggregated immune-cell infiltration and deficient blood vessel formation in ICP placentas.
Our study provides a system-level insight into the placental gene-expression profiles of women with mild or severe ICP, and reveals multiple molecular pathways in immune response and blood vessel formation that might contribute to ICP pathogenesis.
妊娠肝内胆汁淤积症(ICP)是一种与妊娠相关的肝脏疾病,可能对胎儿产生潜在的有害影响,尤其是当孕妇血清胆汁酸浓度>40 μM 时。然而,ICP 的病因和发病机制仍不清楚。为了揭示 ICP 患者母血清胆汁酸水平与胎儿结局之间的潜在分子机制,我们应用 DNA 微阵列技术来描述来自健康孕妇和 ICP 患者的胎盘的全基因组表达谱。
本研究共招募了 30 名孕妇,平均分为三组:健康组;轻度 ICP,血清胆汁酸浓度在 10-40 μM 之间;重度 ICP,胆汁酸浓度>40 μM。通过基因本体论分析结合基因互作和基因共表达网络的构建,鉴定与 ICP 发病机制相关的核心调控基因,并通过定量实时 PCR 和组织学染色进行验证。
核心调控基因主要涉及免疫反应、VEGF 信号通路和 G 蛋白偶联受体信号通路,提示免疫反应、血管生成和血管生成在 ICP 发病机制中起着重要作用。这一推测得到了在 ICP 胎盘观察到的聚集的免疫细胞浸润和血管形成缺陷的支持。
本研究提供了一个系统的视角,了解了轻度或重度 ICP 孕妇的胎盘基因表达谱,并揭示了免疫反应和血管形成中的多个分子途径,这些途径可能有助于 ICP 的发病机制。